Two-way ANOVA with Bonferroni post hoc test (Fig. 6) showed that patients with BC were characterised by significantly reduced methylation levels of SOD2 promoter compared to the control group in women and men subgroups (p < 0.05 and p < 0.001, respectively) (Fig. 6A). This evidence concerns the gene SOD2 and breast cancer.